Companion Diagnostic Assays For Cancer Therapy


A method for classifying cancer patients as eligible to receive cancer therapy comprising determination of the presence or absence in a patient tissue sample of chromosomal copy number gain at chromosomal locus 18q21-q22. The classification of cancer patients based upon the presence or absence of 18q21-q22 gain allows selection of patients to receive chemotherapy, such as therapy with a Bcl-2 family inhibitor, and for monitoring patient response to therapy.

Download PDF
Document Preview
Document History
  • Publication: Jul 10, 2008
  • Application: Dec 28, 2007
    WO US 2007/0026526 W
  • Priority: Dec 28, 2006
    US US 64691006 A

Download Citation

Sign in to the Lens